Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test
Clinical trial NCT03864978 · UNKNOWN
Trial details
- NCT number
- NCT03864978
- Sponsor
- Alfasigma S.p.A.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-22
- Primary completion
- 2020-04-01
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.